This Maven is the Co-Founder and CEO of Maven, the Global Knowledge Marketplace. He has over a decade of experience in high technology, investment research, and knowledge consulting services. As CEO of Maven, he has led the development of the world's first online microconsulting service, providing a unique opportunity for knowledge seekers to gain quick, direct insights from a vast global network of tens of thousands of professionals across all sectors, industries, and functional roles.
He began his career at Applied Materials, the world's leading provider of semiconductor capital equipment and services, where he held a variety of roles in engineering, product support, and business management and became one of the world's leading authorities on High Density Plasma Chemical Vapor Deposition (HDP-CVD). Subsequently, he served as the West Coast head of the Technology, Media, and Telecommunications practice at Gerson Lehrman Group, a global firm providing expert consulting services to large asset management firms. Most recently he served as the Director of Paid Research and Events at ThinkEquity Partners, a boutique growth-focused investment bank and institutional brokerage, where he led efforts to develop new markets and revenue sources for sell-side research products.
This Maven's expertise includes institutional-grade equity research, offshore web development, online professional networking, knowledge characterization, semantic search, and web-enabled telephony systems.
Currently serve as CSO of Maven Research, Inc., a privately held company that operates the Global Knowledge Marketplace. Members of Maven's professional network connect, consult, and profit from what they know. Developed concept for Maven and drove formation of the company, construction of core technology platform, recruitment and growth of knowledge network, and launch of transactional micro-consulting service.
Served as ThinkEquity Partners' Director of Paid Research & Events, a role created with the goal of driving new revenue opportunities from existing institutional-focused research products, reporting directly to the CEO. Supervised all activities relating to the firm's investor conferences, particularly content creation, sales and marketing, and day-of-show operations. Negotiated contracts with and oversaw activities of key vendors, including external conference coordinators, web developers, media planners, and venue personnel. Delivered over $500,000 in new revenue from sponsorships and paid attendance at ThinkEquity Partners' 2007 conferences. Increased overall attendance at ThinkEquity Partners' investor events by over 30%. Developed new event concepts, including ThinkClinic - An Educational Forum for Healthcare Investors and ThinkGreen - The Premier Gathering for GreenTech Industry Executives, Investors, Influencers, and Policymakers. Worked extensively with both Research and Investment Banking divisions to develop content and formulate marketing strategies. Developed technology-based platform for aggregation, distribution, and monetization of multiple forms of investment research, including written reports, audio/video, social and expert networks, and outsourced company analysis.
Managed the Technology, Media, and Telecommunications practice for Western US at Gerson Lehrman Group, the world's largest independent primary research firm. GLG is a subscription-based service that connects asset managers to thought leaders in industry, technology, and the professions for the purpose of investment research and due diligence. Personally supported over 500 individual clients across approximately 40 client firms representing the largest asset management firms on the West Coast. Clients include hedge funds, mutual funds, private equity firms, venture capital funds, and consulting firms. Supervised a team of Research Managers supporting nearly 100 TMT client firms in the western states. Increased annual TMT revenue from West Coast clients from less than $2.5M to greater than $4.0M via sales to new clients and upgrades to existing subscriptions. Drove key initiative to increase usage of GLG service by private equity and venture capital clients that resulted in a 10-fold increase in the number of subscriptions and revenue from PE/VC funds.
Drove market positioning and sales of Applied Materials' Dielectric Chemical Vapor Deposition (DCVD) systems and solutions at major semiconductor manufacturers in the United States and Europe. Customers supported included IBM, STMicroelectronics, Philips Semiconductors, Freescale Semiconductor, etc. Developed product penetration strategy, product placement and differentiation, pricing, negotiation, bookings and revenue forecasting, and competitive intelligence. Coordinated activities of multiple product managers, sales associates, and support personnel and oversaw operations personnel to ensure correct configuration and on-time delivery of products. Responsible for over $55M in new orders and $65M in revenue in Fiscal Year 2003. Increased Dielectric CVD market share at IBM Microelectronics from <30% in 2002 to >90% in 2003, resulting in nearly $400M in new business for Applied Materials across all IBM technology alliance partners (AMD, Chartered Semiconductor, Samsung, Sony, and Toshiba)
• Directly supervised a team of “Total Product Support†engineers responsible for providing advanced technical expertise to field personnel supporting the Western Hemisphere installed-base of High-Density Plasma Chemical Vapor Deposition (HDP-CVD) semiconductor wafer processing equipment. • Personal responsibilities included strategic planning, advanced technical support, contribution to strategic marketing decision-making, communication of technical issues to the product development organization, identification and elimination of flaws in equipment design, Installation and Warranty (I&W) budgeting and tracking. • Held direct responsibility for the overall performance of a global installed base of over $1 billion worth of semiconductor equipment. • Managed a key initiative resulting in a >40% net reduction in installation and warranty spending for new HDP-CVD equipment. This effort earned my team the Applied Materials Team Quarterly Award. • Received Applied Materials Outstanding Contribution Award for leadership role in enhancing the value of Applied Materials Field Support at STMicroelectronics. • Traveled extensively and lived abroad, often managing the team remotely from field offices in France and Italy. • Developed expert-level knowledge of the High Density Plasma Chemical Vapor Deposition (HDP-CVD) process and the Applied Materials Ultima™ HDP-CVD system. • Provided advanced technical support to Applied Materials customers worldwide. • Received Applied Materials Outstanding Contribution Award for the extremely successful installation and startup of the first HDP-CVD system in the People's Republic of China • Spent one year (1999-2000) in Singapore supporting the growth of the company’s business in Southeast Asia
Participated in "NCG", a highly selective six-month rotational training program for recent graduates from the top engineering universities in the United States. Completed three five-week projects in engineering, manufacturing, and field sales organizations, as well as a six-month team capstone project.
1994 - 1998
Bachelor of Science (BS)
Materials Science & Engineering
Creating a profile is quick, easy and free.
AI-generated summaries, automated survey platforms, and quantitative panels have made it easier than ever to collect physician data at scale. A screener can be built in minutes. A survey can go out to thousands of physicians overnight. An AI tool can synthesize the responses before anyone on the research team has finished their coffee. Speed and scale have never been more available.
But speed and scale were never the hard part. The hard part, now more than ever, is capturing something real: physician insight.
As quantitative instruments and AI-assisted research become the default, physicians are on the receiving end of more automated, templated, multiple-choice outreach than at any point before. And predictably, that volume is producing diminishing returns. Physicians are not short on opportunities to engage. They’re short on reasons to believe any single interaction will surface something meaningful. The organizations that recognize this, and that make room for real human interaction alongside their automated tools, have a genuine opportunity to differentiate.
Physicians are surrounded by touchpoints: rep visits, digital content, webinars, research portals, and a growing wave of AI-optimized survey outreach. The issue was never access. The issue is whether any of it earns attention, and a checkbox instrument, however efficiently distributed, rarely does.
Every interaction now competes for an increasingly limited amount of clinical bandwidth, and the variable that determines whether a physician engages isn’t how efficiently the outreach was built. It’s trust. The question isn’t how often physicians are reached. It’s whether the moments created for them deliver something worth their time, and that’s precisely where quantitative, automated approaches tend to fall short. A five-point Likert scale can tell you what a physician selected. It can’t tell you why, what nuance they were weighing, or what they’d have said if someone had simply asked a good follow-up question.
Physician burnout and shrinking bandwidth are the operating reality the research and advisory industry have to design around. Practicing medicine has gotten harder, workloads have intensified, and physicians are noticeably more selective about where they spend time. Generic outreach, especially the kind that’s obviously automated or templated, reads as exactly that: a failure to respect their expertise and their time.
None of this means physicians are checking out. It means they’re filtering harder than ever, and attention has to be earned. An AI-drafted survey that could have been sent to anyone is easy to filter out. A genuine, well-scoped conversation is much harder to ignore.
Here’s the opportunity hiding in plain sight: physicians largely still want to participate in research and advisory work. Many enjoy contributing to it, believe it genuinely helps organizations understand physician insights and needs, and want their perspective to inform real decisions. What they’re rejecting isn’t engagement, its extraction disguised as efficiency.
This is exactly where qualitative, human-led formats (one-on-one interviews, small advisory panels, in-person conversations) outperform automated quantitative tools, especially now. When a physician is reasoning through a nuanced clinical question in their own words, with someone who can ask a real follow-up, they’re not just generating a data point. They’re contributing judgment that took decades to build. That distinction is invisible to a multiple-choice form and is exactly what AI-generated synthesis struggles to reconstruct after the fact. You cannot automate your way to the kind of insight that comes from a physician thinking out loud in real time.
This isn’t an argument against quantitative research or AI tools altogether, they have real value for scale, benchmarking, and pattern detection across large populations. But as those tools become ubiquitous and physicians become more attuned to being “processed” by them, the relative value of genuine human interaction goes up, not down. The scarcer real conversation becomes, the more it stands out, and the more physicians notice and appreciate it.
One assumption worth challenging is the belief that shorter, faster, and more automated is better. In practice, many physicians are comfortable with longer, more substantive engagements (a 45-60-minute conversation, even) as long as the topic is relevant, the format respects their expertise, and the compensation reflects what’s being asked of them.
Brevity and automation have become a stand-in for respect. But that’s the wrong proxy. If the topic matters and the exchange feel fair, physicians will give more of their time and more of themselves to a real conversation than to a quick automated form. The better principle: design for value and let value – not the pressure to scale – determine the format.
If the goal is to capture real insight rather than just more data, a few principles stand out:
As AI and automated quantitative tools become the default way the industry reaches physicians, the organizations that stand out will be the ones still willing to have an actual conversation. Every touch point is a chance to either build trust with a physician or spend it down. In a landscape increasingly filled with automated outreach, real human interaction isn’t just a nicer experience for physicians. It’s becoming the only reliable way to capture insight that’s actually true.
This is the exact problem a vetted expert network is designed to solve. Rather than relying on broad panels and automated instruments to approximate what physicians think, a well-curated expert network connects you directly with the right specialist for a real conversation: a live interview, an advisory session, a genuine exchange of judgment rather than checkboxes.
Looking for qualified experts, matched thoughtfully? Hoping to engage through real human interaction designed to respect your time and expertise?
Reach out to us, we’d love to support you.
The post Physician Insight: Human Interviews vs. AI Surveys appeared first on Maven Research.